IRINOTECAN ACCORD

Concentrate for solution for infusion, 20mg/ml
RxActive license

Active substance (INN)

irinotecan

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength20mg/ml
PackagingUkupno 1 bočica staklena sa 5ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAccord Healthcare Polska Sp. z o.o. Magazyn Importera, Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01CE02)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateJuly 21, 2023

Analogs in Montenegro

7

Other medicines with the same active substance

IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
IRINOTECAN ACCORDRx
Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
IRINOTECAN QILURx
Concentrate for solution for infusion, 40mg/2mlKymos
IRINOTECAN QILURx
Concentrate for solution for infusion, 100mg/5mlKymos
IRITECRx
Concentrate for solution for infusion, 100mg/5mlVianex S.A. - Plant C
IRITECRx
Concentrate for solution for infusion, 40mg/2mlVianex S.A. - Plant C
ONIVYDE PEGYLATED LIPOSOMALRx
Concentrate for dispersion for infusion, 4.3mg/mlLes Laboratoires Servier Industrie
Source: CInMED register